• 1
    Landsteiner K, Jacobs J. Studies on the sensitization of animals with simple chemical compounds. J Exp Med 1935; 61: 643656.
  • 2
    Weltzien HU, Padovan E. Molecular features of penicillin allergy. J Invest Dermatol 1998; 110: 203206.
  • 3
    Naisbitt DJ, Gordon SF, Pirmohamed M, Park BK. Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug Saf 2000; 23: 483507.
  • 4
    Pichler WJ. Drug Hypersensitivity in Allergy and Allergic Diseases. (edited by KayB, KaplanA, BousquetJ, HoltP). Oxford: Wiley-Blackwell 2008.
  • 5
    Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139: 683693.
  • 6
    Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol 2002; 2: 301305.
  • 7
    Pichler WJ, Beeler A, Keller M et al. Pharmacological interaction of drugs with immune receptors: the p-i concept. Allergol Int 2006; 55: 1725.
  • 8
    Pichler WJ. Direct T-cell stimulations by drugs--bypassing the innate immune system. Toxicology 2005; 209: 95100.
  • 9
    Geiger R, Duhen T, Lanzavecchia A, Sallusto F. Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J Exp Med 2009; 206(7): 15251534.
  • 10
    Mockenhaupt M, Viboud C, Dunant A et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008; 128(1): 3544.
  • 11
    Hirahara K, Kano Y, Mitsuyama Y, Takahashi R, Kimishima M, Shiohara T. Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions. Clin Exp Dermatol 2010; 35: 863868.
  • 12
    Hari Y, Frutig-Schnyder K, Hurni M et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001; 31(9): 13981408.
  • 13
    Kano Y, Shiohara T. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am 2009; 29: 481501.
  • 14
    Mennicke M, Zawodniak A, Keller M et al. Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation. Am J Transplant 2009; 9(9): 21972202.
  • 15
    Mardivirin L, Valeyrie-Allanore L, Branlant-Redon E et al. Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpes virus 6 replication in vitro. Eur J Dermatol 2010; 20(1): 6873.
  • 16
    Beeler A, Engler O, Gerber BO, Pichler WJ. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J Allergy Clin Immunol 2006; 117: 455462.
  • 17
    Mauri-Hellweg D, Zanni M, Frei E et al. Cross-reactivity of T cell lines and clones to beta-lactam antibiotics. J Immunol 1996; 157(3): 10711079.
  • 18
    Zanni MP, Mauri-Hellweg D, Brander C et al. Characterization of lidocaine-specific T cells. J Immunol 1997; 158(3): 11391148.
  • 19
    Zanni MP, von Greyerz S, Hari Y, Schnyder B, Pichler WJ. Recognition of local anesthetics by alphabeta+ T cells. J Invest Dermatol 1999; 112(2): 197204.
  • 20
    Sullivan TJ, Remedios C, Ong MD, Gilliam LK. Studies of the multiple drug allergy syndrome. J Allergy Clin Immunol 1989; 83: 270.
  • 21
    Asero R. Multiple drug allergy syndrome: a distinct clinical entity. Curr Allergy Rep 2001; 1(1): 1822.
  • 22
    Gex-Collet C, Helbling A, Pichler WJ. Multiple drug hypersensitivity--proof of multiple drug hypersensitivity by patch and lymphocyte transformation tests. J Investig Allergol Clin Immunol 2005; 15(4): 293296.
  • 23
    Neukomm CB, Yawalkar N, Helbling A, Pichler WJ. T-cell reactions to drugs in distinct clinical manifestations of drug allergy. J Investig Allergol Clin Immunol 2001; 11(4): 275285.
  • 24
    Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 2009; 182: 80718079.
  • 25
    Kanny G, Pichler W, Morisset M et al. T cell-mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activation tests. J Allergy Clin Immunol 2005; 115(1): 179185.